Inventor · disambiguated record
Datong Tang
Also filed as: TANG DATONG
33 granted patents·6 pending applications·383 citations·filing 2003–2024
97Inventor score
Top patents by PatentIndex Score
39 records- 0197US7176208B2Quinoxalinyl macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2004·Granted Feb 13, 2007·111 cites·10 claims
- 0296US7601709B2Macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2004·Granted Oct 13, 2009·60 cites·75 claims
- 0396US7368452B2Quinoxalinyl macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2006·Granted May 6, 2008·35 cites·12 claims
- 0496US7273851B2Tri-peptide hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2004·Granted Sep 25, 2007·65 cites·18 claims
- 0593US7566719B2Quinoxalinyl macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2008·Granted Jul 28, 2009·20 cites·8 claims
- 0691US8426458B2Hepatitis C Virus inhibitorsOR YAT SUN·Filed 2010·Granted Apr 23, 2013·10 cites·30 claims
- 0789US8124584B2Macrocyclic hepatitis C serine protease inhibitorsMIAO ZHENWEI·Filed 2009·Granted Feb 28, 2012·6 cites·46 claims
- 0889US7384921B2Polymorphic forms of 6-11 bicyclic ketolide derivativesENANTA PHARM INC·Filed 2005·Granted Jun 10, 2008·11 cites·10 claims
- 0987US12377078B2Viral inhibitors, the synthesis thereof, and intermediates theretoTAKEDA PHARMACEUTICALS CO·Filed 2024·Granted Aug 5, 2025·0 cites·26 claims
- 1087US12295941B2Viral inhibitors, the synthesis thereof, and intermediates theretoTAKEDA PHARMACEUTICALS CO·Filed 2024·Granted May 13, 2025·0 cites·20 claims
- 1187US12295940B2Viral inhibitors, the synthesis thereof, and intermediates theretoTAKEDA PHARMACEUTICALS CO·Filed 2024·Granted May 13, 2025·0 cites·20 claims
- 1287USRE42375EQuinoxalinyl macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2008·Granted May 17, 2011·7 cites·14 claims
- 1386US8420686B2Linked diimidazole antiviralsOR YAT SUN·Filed 2010·Granted Apr 16, 2013·11 cites·32 claims
- 1485US7291602B211,12-lactone bicyclolidesENANTA PHARM INC·Filed 2005·Granted Nov 6, 2007·9 cites·23 claims
- 1584US2024189286A1Viral inhibitors, the synthesis thereof, and intermediates theretoTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1683US7718769B2Tri-peptide hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2006·Granted May 18, 2010·4 cites·10 claims
- 1783US7538225B2Processes for the preparation of o-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamineENANTA PHARM INC·Filed 2005·Granted May 26, 2009·3 cites·9 claims
- 1883US2024277748A1Viral inhibitors, the synthesis thereof, and intermediates theretoTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1982US8778938B2Hepatitis C virus inhibitorsQIU YAO-LING·Filed 2011·Granted Jul 15, 2014·3 cites·26 claims
- 2082US7229972B23,6-BicyclolidesENANTA PHARM INC·Filed 2004·Granted Jun 12, 2007·15 cites·37 claims
- 2179US7718612B2Pyridazinonyl macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2007·Granted May 18, 2010·1 cites·4 claims
- 2278US8921573B2Processes for the preparation of novel benzimidazole derivativesENANTA PHARM INC·Filed 2014·Granted Dec 30, 2014·2 cites·15 claims
- 2377US7419962B23,6-bicyclolidesENANTA PHARM INC·Filed 2005·Granted Sep 2, 2008·3 cites·47 claims
- 2475US8501681B2Macrocyclic hepatitis C virus serine protease inhibitorsNIU DEQIANG·Filed 2007·Granted Aug 6, 2013·2 cites·15 claims
- 2575US7517859B2Spirocyclic bicyclolidesENANTA PHARM INC·Filed 2006·Granted Apr 14, 2009·2 cites·11 claims
- 2675US7312201B2Tetracyclic bicyclolidesENANTA PHARM INC·Filed 2005·Granted Dec 25, 2007·2 cites·23 claims
- 2768US7842813B2Processes for the preparation of O-[5-(4-amino-thiazol-2-yl)-pyridin-2-ylmethyl]-hydroxylamineENANTA PHARM INC·Filed 2009·Granted Nov 30, 2010·1 cites·12 claims
- 2864US7919627B2Processes for the preparation of hydroxylaminesENANTA PHARM INC·Filed 2008·Granted Apr 5, 2011·0 cites·10 claims
- 2962US8236807B2Quinoxalinyl macrocyclic hepatitis C serine protease inhibitorsNAKAJIMA SUANNE·Filed 2009·Granted Aug 7, 2012·0 cites·7 claims
- 3061US9242974B2Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivativesENANTA PHARM INC·Filed 2013·Granted Jan 26, 2016·0 cites·11 claims
- 3161US8552162B2Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivativesXU GUOYOU·Filed 2009·Granted Oct 8, 2013·0 cites·23 claims
- 3259US2009005387A1Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitorsNIU DEQIANG·Filed 2008·Application pending·0 cites
- 3357US2008248105A1Polymorphic forms of 6-11 bicyclic ketolide derivativesTANG DATONG·Filed 2008·Application pending·0 cites
- 3456US8809264B2Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitorsNIU DEQIANG·Filed 2007·Granted Aug 19, 2014·0 cites·15 claims
- 3552US8962551B2Quinoxalinyl derivativesNIU DEQIANG·Filed 2008·Granted Feb 24, 2015·0 cites·15 claims
- 3651US2004180815A1Pyridazinonyl macrocyclic hepatitis C serine protease inhibitorsFiled 2003·Application pending·0 cites
- 3748US8927739B2Processes for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivativesENANTA PHARM INC·Filed 2013·Granted Jan 6, 2015·0 cites·11 claims
- 3841US2009035267A1Acyclic, pyridazinone-derived hepatitis c serine protease inhibitorsMOORE JOEL D·Filed 2007·Application pending·0 cites
- 3939US8609648B2Hepatitis C virus inhibitorsOR YAT SUN·Filed 2010·Granted Dec 17, 2013·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Datong Tang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →